"The Next Big Thing"

BIOTECH SLEEPING GIAN

I do represent this company, but if you want a potential giant, read on.....

Bioheart, NASDAQ: BHRT. BHRT has a proprietary muscle stem cell removal, culturing, and injection process where thigh muscle stem cells are harvested from the patient, cultured (grown), and then injected into the patient suffering from heart failure. The injected muscle stem cells regrow and repair damaged heart muscle. They are in the tail end of Phase III clinical trials and are going for FDA Approval in Q409 = MASSIVE. They also have nine new patents just announced covering the electronic stimulation of muscle stem cells, both in the cultured stage and after they have been injected, in which the patented electronic stimulus "teaches" the muscle stem cells to function like heart muslce.

The cost of the treatment is $35-40K compared to other heart failure treatments such as drug prescriptions which run over $60K a year, ventricular assist devices which cost $250K, and heart transplant which costs $500K. The US market alone for BHRT is $3 billion. If BHRT hits just 2% of their target market, they will have revs of over $500M.

The management of BHRT were some of the key players from World Medical, which were bought by Medtronic in a deal valued at $4B. The guys know what they are doing and are sitting on a gold mine of a company.

Stock is currently trading at $1.20 and was hovering around $3 two months ago. Hugely undervalued, strategic buying opportunity, potential gold mine.